Related references
Note: Only part of the references are listed.VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
Jan Sperveslage et al.
ACTA NEUROPATHOLOGICA (2013)
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
Christian Koelsche et al.
ACTA NEUROPATHOLOGICA (2013)
Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
Bette Kay Kleinschmidt-DeMasters et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
M. Ilie et al.
ANNALS OF ONCOLOGY (2013)
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
Hans Boesmueller et al.
HUMAN PATHOLOGY (2013)
Detection of BRAF p.V600E Mutations in Melanomas Comparison of Four Methods Argues for Sequential Use of Immunohistochemistry and Pyrosequencing
Emeline Colomba et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma
John K. Feller et al.
MODERN PATHOLOGY (2013)
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
David Capper et al.
ACTA NEUROPATHOLOGICA (2012)
Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia
Mindaugas Andrulis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma
Oskar Koperek et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma
M. Bullock et al.
ENDOCRINE-RELATED CANCER (2012)
BRAF Duplications and MAPK Pathway Activation Are Frequent in Gliomas of the Optic Nerve Proper
Fausto J. Rodriguez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549:BRAF Fusion Variants
Alex Lin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1
Alexander Skorokhod et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region
Benhur Amanuel et al.
PATHOLOGY (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
Dora Dias-Santagata et al.
PLOS ONE (2011)
BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes
Hazem El-Osta et al.
PLOS ONE (2011)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
Tim Forshew et al.
JOURNAL OF PATHOLOGY (2009)
RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations
Judith Jeuken et al.
ACTA NEUROPATHOLOGICA (2007)
Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
V Emuss et al.
CANCER RESEARCH (2005)
Mutation analysis of B-RAF gene in human gliomas
D Basto et al.
ACTA NEUROPATHOLOGICA (2005)
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
CB Knobbe et al.
ACTA NEUROPATHOLOGICA (2004)
The RAF proteins take centre stage
C Wellbrock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
